Literature DB >> 5558777

Absorption and metabolism of L-dopa by the human stomach.

L Rivera-Calimlim, C A Dujovne, J P Morgan, L Lasagna, J R Bianchine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5558777     DOI: 10.1111/j.1365-2362.1971.tb00637.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  19 in total

1.  Proceedings: A microsomal oxidase system in rat intestinal mucosa.

Authors:  S H Curry; G P Mould
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.

Authors:  D R Robertson; I Higginson; B S Macklin; A G Renwick; D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

3.  Plasma dopa concentrations after different preparations of levodopa in normal subjects.

Authors:  J G Morris; R L Parsons; J R Trounce; M J Groves
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

Review 4.  Antacid therapy and drug kinetics.

Authors:  A Hurwitz
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 5.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease.

Authors:  A K Granerus; R Jagenburg; A Svanborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa.

Authors:  L Rivera-Calimlim
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

8.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 9.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

10.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.